Norman James Gutteridge

Title: Innovations of Norman James Gutteridge

Introduction

Norman James Gutteridge is a notable inventor based in Owlsmoor, near Camberley, England. He has made significant contributions to the field of chemistry, particularly in the development of anti-thrombotic agents. With a total of 4 patents to his name, Gutteridge's work has had a meaningful impact on medical science.

Latest Patents

Gutteridge's latest patents include innovative compounds such as cyclopentone propanoic acid derivatives. These compounds are characterized by the formula where R¹ is a C₁-₈ alkyl group, optionally substituted by hydroxyl or --COOH, and R² is hydrogen or a protecting group. They are recognized for their utility as anti-thrombotic agents. Another significant invention is the 3-substituted propanoic acid derivatives, which provide 3-(2-formyl-3-hydroxy-5-oxocyclopent-1-enyl)-propanoic acid and its derivatives. These compounds exhibit anti-thrombotic activity coupled with low toxicity, and a method for their preparation involves oxidative cleavage of specific precursors.

Career Highlights

Gutteridge is currently associated with Lilly Industries, Inc., where he continues to innovate and develop new chemical compounds. His work has been instrumental in advancing therapeutic options for patients requiring anti-thrombotic treatments.

Collaborations

Throughout his career, Gutteridge has collaborated with esteemed colleagues such as William Dawson and Michael John Foulis. These partnerships have fostered a collaborative environment that enhances the research and development of new inventions.

Conclusion

Norman James Gutteridge's contributions to the field of chemistry, particularly in anti-thrombotic agents, highlight his innovative spirit and dedication to improving medical treatments. His patents and collaborations reflect a commitment to advancing science for the benefit of society.